Related Experiment Videos
Summary
Mianserin, a drug for depression, may cause agranulocytosis, a serious blood disorder. This case highlights the importance of monitoring new medications like mianserin for potential adverse effects.
Area of Science:
- Pharmacology
- Hematology
- Clinical Toxicology
Background:
- A patient with alcoholism and hypothyroidism was treated for depression.
- Thyroxine was prescribed for hypothyroidism, and mianserin for depression.
Observation:
- The patient developed severe illness after several weeks of treatment.
- Hematological examination revealed agranulocytosis, a critical drop in white blood cells.
Findings:
- Extensive investigations ruled out other causes for agranulocytosis.
- Thyroxine, used for years without reported similar effects, was deemed unlikely to be the cause.
- Mianserin was identified as the probable cause of the drug-induced agranulocytosis.
Implications:
- This case suggests a potential link between mianserin and agranulocytosis.
- It underscores the need for vigilant monitoring of new drugs during their early widespread use.
- Healthcare providers should consider mianserin as a potential cause of agranulocytosis in patients presenting with relevant symptoms.